tiprankstipranks
Advertisement
Advertisement

TEVA Stock Latest News

Aurinia settles patent litigation with Teva
The FlyAurinia settles patent litigation with Teva
6d ago
AUPH
TEVA
TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer
PremiumMarket News
TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer
6d ago
TEVA
Teva announces FDA acceptance of ecopipam NDA
PremiumThe Fly
Teva announces FDA acceptance of ecopipam NDA
6d ago
TEVA
Teva price target raised to $42 from $40 at Barclays
PremiumThe Fly
Teva price target raised to $42 from $40 at Barclays
9d ago
TEVA
Teva call volume above normal and directionally bullish
PremiumThe Fly
Teva call volume above normal and directionally bullish
9d ago
TEVA
Teva: Buy Rating Reiterated as Analyst Sees Listing and Pipeline Upside, Keeps $42 Price Target Unchanged
PremiumRatingsTeva: Buy Rating Reiterated as Analyst Sees Listing and Pipeline Upside, Keeps $42 Price Target Unchanged
18d ago
TEVA
AI Models Turn More Constructive on Teva Pharmaceutical (TEVA) as Earnings and Margins Improve
Premium
AI Analyst Ratings
AI Models Turn More Constructive on Teva Pharmaceutical (TEVA) as Earnings and Margins Improve
26d ago
TEVA
Teva Earnings Call Highlights Innovative Growth Shift
Premium
Company Announcements
Teva Earnings Call Highlights Innovative Growth Shift
27d ago
TEVA
Morning Movers: Generac, Amphenol climb following earnings
PremiumThe Fly
Morning Movers: Generac, Amphenol climb following earnings
27d ago
F
V
Teva says ‘clear path’ to 30% operating margin by 2027
PremiumThe Fly
Teva says ‘clear path’ to 30% operating margin by 2027
27d ago
TEVA
Teva says biosimilars a growth pipeline for the company
PremiumThe Fly
Teva says biosimilars a growth pipeline for the company
28d ago
TEVA
Teva reports Q2 EPS 2c, consensus 11c
PremiumThe Fly
Teva reports Q2 EPS 2c, consensus 11c
28d ago
TEVA
Teva backs FY26 EPS view $1.91-$2.11, consensus $2.16
PremiumThe FlyTeva backs FY26 EPS view $1.91-$2.11, consensus $2.16
28d ago
TEVA
These Are the Stocks Reporting Earnings Today – July 29, 2026
Premium
Market News
These Are the Stocks Reporting Earnings Today – July 29, 2026
28d ago
GD
PG
First Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
Premium
The Fly
First Tracks Biotherapeutics price target raised to $60 from $30 at Wedbush
29d ago
ARGX
FBRX
Teva price target raised to $44 from $42 at Piper Sandler
PremiumThe Fly
Teva price target raised to $44 from $42 at Piper Sandler
29d ago
TEVA
Is TEVA a Buy, Before Earnings?
PremiumPre-Earnings
Is TEVA a Buy, Before Earnings?
30d ago
TEVA
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
PremiumTipRanks Newswire
Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)
1M ago
CHKP
COIN
Teva, Polpharma enter global licensing agreement for Ocrevus biosimilar
PremiumThe Fly
Teva, Polpharma enter global licensing agreement for Ocrevus biosimilar
2M ago
TEVA
Teva, Polpharma Biologics announce global licensing agreement
PremiumThe FlyTeva, Polpharma Biologics announce global licensing agreement
2M ago
TEVA
Teva, Samsung Bioepis enter commercialization agreement for OPUVIZ
Premium
The Fly
Teva, Samsung Bioepis enter commercialization agreement for OPUVIZ
2M ago
TEVA
Teva to advance TEV-‘408 into Phase 2b study in vitiligo in Q4
Premium
The Fly
Teva to advance TEV-‘408 into Phase 2b study in vitiligo in Q4
2M ago
TEVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >